Sandbox:UT: Difference between revisions

Jump to navigation Jump to search
Usama Talib (talk | contribs)
Usama Talib (talk | contribs)
 
(53 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{| class="wikitable"
! colspan="14" align="center" style="background:#4479BA; color: #FFFFFF;" + |Wikidoc Internal Medicine Texbook
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Subject
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Endocrinology
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Gastroenterology
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Rheumatology
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Pulmonology
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Nephrology
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Hematology
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Total
|-
| rowspan="2" |'''Number of Microchapters'''
|'''Total'''
|'''Left'''
|'''Total'''
|'''Left'''
|'''Total'''
|'''Left'''
|'''Total'''
|'''Left'''
|'''Total'''
|'''Left'''
|'''Total'''
|'''Left'''
|-
|71
|'''39'''
|96
|'''89'''
|54
|'''47'''
|58
|'''46'''
|59
|'''64'''
|51
|'''47'''
|'''332'''
|-
|'''Projected Microchapters'''
| colspan="2" |50
| colspan="2" |111
| colspan="2" |59
| colspan="2" |59
| colspan="2" |80
| colspan="2" |59
|418
|-
|'''Days Projected'''
* If one chapter takes 10 days/fellow
* Number of fellows = 15
* 15 chapters are completed in 10 days
| colspan="2" |35 days
| colspan="2" |75 days
| colspan="2" |40 days
| colspan="2" |40 days
| colspan="2" |55 days
| colspan="2" |40 days
|280 days
|-
|'''Review Processing Time (days)'''
| colspan="2" |14
| colspan="2" |14
| colspan="2" |14
| colspan="2" |14
| colspan="2" |14
| colspan="2" |14
|84 days
|-
|'''Expected Time for each Chapter (days)'''
| colspan="2" |49
| colspan="2" |89
| colspan="2" |54
| colspan="2" |54
| colspan="2" |69
| colspan="2" |54
|364 days
|-
|'''Expected Time line'''
| colspan="2" |October 2017, 1st week
| colspan="2" |January 2018,1st week
| colspan="2" |February 2018, 4th week
| colspan="2" |April 2018, 3rd week
| colspan="2" |July 2018, 1st week
| colspan="3" |'''August 2018,  4th week'''
|}
{| class="wikitable"
! colspan="16" align="center" style="background:#4479BA; color: #FFFFFF;" + |Wikidoc Other Textbooks
|-
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Subject
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Psychiatry
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Neurology
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Peds/Developmental
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Dermatology
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |ObGyn
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Ophthalmology
! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Nutrition
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Total
|-
| rowspan="2" |'''Number of Microchapters'''
|'''Total'''
|'''Left'''
|'''Total'''
|'''Left'''
|'''Total'''
|'''Left'''
|'''Total'''
|'''Left'''
|'''Total'''
|'''Left'''
|'''Total'''
|'''Left'''
|Total
|Left
|-
|36
|'''36'''
|77
|'''71'''
|49
|'''49'''
|18
|'''14'''
|33
|'''27'''
|18
|'''17'''
|17
|'''15'''
|'''229'''
|-
|'''Projected Microchapters'''
| colspan="2" |45
| colspan="2" |89
| colspan="2" |60
| colspan="2" |17
| colspan="2" |35
| colspan="2" |21
| colspan="2" |19
|286
|-
|'''Days projected'''
* If one chapter takes 10 days/fellow
* Number of fellows = 15
* 15 chapters are completed in 10 days
| colspan="2" |30 days
| colspan="2" |60 days
| colspan="2" |40 days
| colspan="2" |14 days
| colspan="2" |21 days
| colspan="2" |16 days
| colspan="2" |15 days
|196 days
|-
|'''Review Processing Time (days)'''
| colspan="2" |14
| colspan="2" |14
| colspan="2" |14
| colspan="2" |14
| colspan="2" |14
| colspan="2" |14
| colspan="2" |14
|98 days
|-
|'''Expected Time for each Chapter (days)'''
| colspan="2" |44
| colspan="2" |74
| colspan="2" |54
| colspan="2" |28
| colspan="2" |35
| colspan="2" |30
| colspan="2" |29
|294 days
|-
|'''Expected Time Line'''
| colspan="2" |October 2018, 3rd week
| colspan="2" |January 2019, 1st week
| colspan="2" |March 2019, 1st week
| colspan="2" |April 2019, 1st week
| colspan="2" |May 2019, 2nd week
| colspan="2" |June 2019, 2nd week
| colspan="3" |'''July 2019, 2nd week'''
|}
{{familytree/start}}
{{familytree | | | | | | | | | | | | | A01 | | | | | |A01='''Viral Hepatitis'''}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | }}
{{familytree | |,|-|-|-|v|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|v|-|-|-|.| | }}
{{familytree | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| }}
{{familytree | D01 | |D02| | D03 | | D04 | |D05| | D06 | | D07 | |D08| | |D01=[[Hepatitis A]]|D02=[[Hepatitis B]]|D03=[[Hepatitis C]]|D04=[[Hepatitis D]]|D05=[[Hepatitis E]]|D06=[[Hepatitis F]]|D07=[[Hepatitis G]]|D08=Other}}
{{familytree | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |!| }}
{{familytree |boxstyle=text-align: left; | | | | | | | | | | | | | | | | | | | | | | | | | | | | | E01 |E01= • [[Mononucleosis natural history#Complications|EBV hepatitis]]<br>• [[Cytomegalovirus infection natural history, complications and prognosis#Complications|CMV hepatitis]] <br>• [[Herpes simplex natural history, complications and prognosis#Complications|HSV hepatitis]] <br>• [[Coxsackie virus#Classification|Coxsackie B virus hepatitis]] <br>}}
{{familytree/end}}
__NOTOC__
__NOTOC__


==code to fix refereneces==
 
<br style="clear:both" />
{{familytree/start}}
{{familytree | | | | | | | | | | | | | A01 | | | | | |A01='''Non-infectious Hepatitis'''}}
{{familytree | | | | | | | | | | | | | |!| | | | | | | | }}
{{familytree | |,|-|-|-|-|-|-|-|v|-|-|-|+|-|-|-|v|-|-|-|v|-|-|-|v|-|-|-|.| | }}
{{familytree | |!| | | | | | | |!| | | |!| | | |!| | | |!| | | |!| | | |!| }}
{{familytree | D01 | | | | | D03 | | D04 | |D05| | D06 | | D07 | |D08| | |D01=[[Alcoholic hepatitis]]|D02=[[Non-alcoholic steatohepatitis]] ([[NASH]])|D03=[[a-1 antitrypsin defieciency]]|D04=[[Autoimmune hepatitis]]|D05=Obstructive hepatitis|D06=Drug related hepatitis|D07=Toxin related hepatitis|D08=Ischemic hepatitis}}
{{familytree | | | | | | | | | | | | | | | | | |!| | | |!| | | |!| | | | | }}
{{familytree |boxstyle=text-align: left; | | | | | | | | | | | | | | | | | E01 | | E02 | | E03 | | | | | |E01=•[[Gall stone]] <br>•Tumor|E02= •[[Isoniazid]]<br>•[[NSAIDs]]<br>•Beta-lactam antibiotics<br>•Sulfa-containing drugs<br>•[[HAART]]|E03=Chemicals}}
{{familytree/end}}
 
==Chest Pain==
 
{|
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="3" |Differentials on the basis of Etiology
! rowspan="3" |Disease
! colspan="10" |Clinical manifestations
! colspan="4" |Diagnosis
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! colspan="8" |Symptoms
! rowspan="2" |Risk factors
! rowspan="2" |Physical exam
! rowspan="2" |Lab Findings
! rowspan="2" |EKG
! rowspan="2" |Imaging
! rowspan="2" |Gold standard
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
!Onset
!Duration
!Quality of Pain
!Cough
!Fever
!Dyspnea
!Weight loss
!Associated Features
|- style="background: #DCDCDC; padding: 5px;" |
|
!'''[[Stable Angina]]'''<ref name="pmid23166211">{{cite journal |vauthors=Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR, Smith SC, Spertus JA, Williams SV, Anderson JL |title=2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons |journal=Circulation |volume=126 |issue=25 |pages=e354–471 |date=December 2012 |pmid=23166211 |doi=10.1161/CIR.0b013e318277d6a0 |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |Sudden (acute)
| style="background: #F5F5F5; padding: 5px;" |2-10 minutes
| style="background: #F5F5F5; padding: 5px;" |
*Heaviness/pressure/ tightness/squeezing/ burning ([[Levine's sign]])
*Retrosternal  or left sided chest pain
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
*[[Nausea and vomiting|Nausea]] and [[vomiting]]
*[[Diaphoresis]]
| style="background: #F5F5F5; padding: 5px;" |Dyslipidemia, hypertension, smoking,  family history of premature disease, and diabetes
| style="background: #F5F5F5; padding: 5px;" |
*Transient [[third heart sound]] [[S3|(S3]] - [[Ventricular|ventricular filling sound]]) and [[fourth heart sound]] ([[S4]] - [[atrial]] filling sound)
| style="background: #F5F5F5; padding: 5px;" |
*Cardiac enzymes normal
| style="background: #F5F5F5; padding: 5px;" |
*Exercise EKG: ST-segment depression
| style="background: #F5F5F5; padding: 5px;" |
*Exercise Stress Testing: Decreased myocardial perfusion
*Transthoracic echocardiography: Ejection fraction <50 percent
| style="background: #F5F5F5; padding: 5px;" |
*Coronary angiography
|- style="background: #DCDCDC; padding: 5px;" |
|
|'''[[Unstable Angina]]'''<ref name="pmid8998090">{{cite journal |vauthors=Tatum JL, Jesse RL, Kontos MC, Nicholson CS, Schmidt KL, Roberts CS, Ornato JP |title=Comprehensive strategy for the evaluation and triage of the chest pain patient |journal=Ann Emerg Med |volume=29 |issue=1 |pages=116–25 |date=January 1997 |pmid=8998090 |doi= |url=}}</ref><ref name="pmid10492848">{{cite journal |vauthors=Ornato JP |title=Chest pain emergency centers: improving acute myocardial infarction care |journal=Clin Cardiol |volume=22 |issue=8 Suppl |pages=IV3–9 |date=August 1999 |pmid=10492848 |doi= |url=}}</ref><ref name="pmid7611601">{{cite journal |vauthors=Gibler WB |title=Evaluation of chest pain in the emergency department |journal=Ann. Intern. Med. |volume=123 |issue=4 |pages=315; author reply 317–8 |date=August 1995 |pmid=7611601 |doi= |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |Acute
| style="background: #F5F5F5; padding: 5px;" |10-20 minutes
| style="background: #F5F5F5; padding: 5px;" |
*Same as stable angina but often more severe
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
*[[Nausea and vomiting]]
*[[Diaphoresis]]
*[[Presyncope]]
*[[Palpitation|Palpitations]]
| style="background: #F5F5F5; padding: 5px;" |Dyslipidemia, hypertension, smoking,  family history of premature disease, and diabetes
| style="background: #F5F5F5; padding: 5px;" |
*Reverse [[Splitting of S2|splitting]] of the [[second heart sound]]
*[[Rales/Crackles|Rales or crackles]]
*[[Elevated jugular venous pressure]]
| style="background: #F5F5F5; padding: 5px;" |
*[[Cardiac Biomarkers|Cardiac biomarkers [Cardiac troponin I, cardiac troponin T]] and [[CK MB|<nowiki>MB isoenzyme of creatine kinase (CK-MB)]</nowiki>]] normal
| style="background: #F5F5F5; padding: 5px;" |
*ST-depression
*New T wave inversions
*Transient ST-elevation
| style="background: #F5F5F5; padding: 5px;" |
*Echocardiography: Ejection fraction <50 percent
*Exercise Stress Testing: Decreased myocardial perfusion
| style="background: #F5F5F5; padding: 5px;" |
*Invasive coronary angiography
|- style="background: #DCDCDC; padding: 5px;" |
|
|'''[[Myocardial Infarction]]'''<ref name="pmid8704488">{{cite journal |vauthors=Svavarsdóttir AE, Jónasson MR, Gudmundsson GH, Fjeldsted K |title=Chest pain in family practice. Diagnosis and long-term outcome in a community setting |journal=Can Fam Physician |volume=42 |issue= |pages=1122–8 |date=June 1996 |pmid=8704488 |pmc=2146490 |doi= |url=}}</ref><ref name="pmid8163958">{{cite journal |vauthors=Klinkman MS, Stevens D, Gorenflo DW |title=Episodes of care for chest pain: a preliminary report from MIRNET. Michigan Research Network |journal=J Fam Pract |volume=38 |issue=4 |pages=345–52 |date=April 1994 |pmid=8163958 |doi= |url=}}</ref><ref name="pmid19883149">{{cite journal |vauthors=Bösner S, Becker A, Haasenritter J, Abu Hani M, Keller H, Sönnichsen AC, Karatolios K, Schaefer JR, Seitz G, Baum E, Donner-Banzhoff N |title=Chest pain in primary care: epidemiology and pre-work-up probabilities |journal=Eur J Gen Pract |volume=15 |issue=3 |pages=141–6 |date= 2009 |pmid=19883149 |doi=10.3109/13814780903329528 |url=}}</ref><ref name="pmid21391528">{{cite journal |vauthors=Ebell MH |title=Evaluation of chest pain in primary care patients |journal=Am Fam Physician |volume=83 |issue=5 |pages=603–5 |date=March 2011 |pmid=21391528 |doi= |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |Acute
| style="background: #F5F5F5; padding: 5px;" |Commonly > 20 minutes
| style="background: #F5F5F5; padding: 5px;" |
*Same as stable angina but often more severe
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
*[[Nausea and vomiting]]
*[[Diaphoresis]]
*[[Presyncope]]
*[[Palpitation|Palpitations]]
*[[Lateral]] [[displacement]] of the [[apical impulse]]
| style="background: #F5F5F5; padding: 5px;" |Dyslipidemia, hypertension, smoking,  family history of premature disease, and diabetes
| style="background: #F5F5F5; padding: 5px;" |
* Hypotension
* Tachycardia
 
*[[S4]] [[Gallop rhythm|gallop]]
*[[Paradoxical splitting of S2]]
*[[Mitral regurgitation]] [[Heart murmur|murmur]]
| style="background: #F5F5F5; padding: 5px;" |
*Elevated [[cardiac enzymes]]
*↑[[Brain natriuretic peptide|B-Type Natriuretic Peptide]]
| style="background: #F5F5F5; padding: 5px;" |
*ST elevation MI (STEMI)
*Non-ST elevation MI (NSTEMI) or Non Q wave
| style="background: #F5F5F5; padding: 5px;" |
*Echocardiography: ↓ EF
*CCTA: Coronory artery stenosis
*CMRI: Coronory vessels stenosis
*MPI on SPECT or PET scanning: Decreased myocardial perfusion.
| style="background: #F5F5F5; padding: 5px;" |
*CCTA combined with MPI
|- style="background: #DCDCDC; padding: 5px;" |
! rowspan="9" |Cardiac
|Vasospastic/ Prinzmetal/ Variant Angina<ref name="pmid14434946">{{cite journal |vauthors=PRINZMETAL M, KENNAMER R, MERLISS R, WADA T, BOR N |title=Angina pectoris. I. A variant form of angina pectoris; preliminary report |journal=Am. J. Med. |volume=27 |issue= |pages=375–88 |date=September 1959 |pmid=14434946 |doi= |url=}}</ref><ref name="pmid3779913">{{cite journal |vauthors=Kaski JC, Crea F, Meran D, Rodriguez L, Araujo L, Chierchia S, Davies G, Maseri A |title=Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina |journal=Circulation |volume=74 |issue=6 |pages=1255–65 |date=December 1986 |pmid=3779913 |doi= |url=}}</ref>
| style="background: #F5F5F5; padding: 5px;" |Gradual in onset and offset
| style="background: #F5F5F5; padding: 5px;" |Episodic, gradual in onset and offset.
| style="background: #F5F5F5; padding: 5px;" |Chest discomfort described as squeezing, tightness, pressure, constriction, strangling, burning, heart burn, fullness in the chest, a band-like sensation, knot in the center of the chest, lump in the throat, ache, and heavy weight on chest
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | +
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* Nausea, sweating, dizziness, dyspnea, and palpitations
* Associated with other vasospastic disorders, such as Raynaud's phenomenon and migraine headache
| style="background: #F5F5F5; padding: 5px;" |
* Multiple drugs (ephedrine-based products, cocaine, marijuana, alcohol, butane, sumatriptan, and amphetamines)
* Food-born botulism
* Guide wire or balloon dilatation while doing PCI
* Magnesium deficiency
| style="background: #F5F5F5; padding: 5px;" |Tachycardia, hypertension, diaphoresis, and a gallop rhythm 
| style="background: #F5F5F5; padding: 5px;" |
* Urine drug screen may be positive for cocaine or other drugs
| style="background: #F5F5F5; padding: 5px;" |
* Transient (less than 15 minutes) ischemic ST changes in multiple leads
* A tall and broad R wave,
* Disappearance of the S wave
* A taller T wave
* Negative U waves
| style="background: #F5F5F5; padding: 5px;" |
* Stress testing: normal noninvasive stress test, exercise-induced spasm with ST-segment elevation,
* Stress echocardiography with ergonovine provocation: Vasospasm of coronory vessels
* Coronary arteriography: Epicardial spasm
| style="background: #F5F5F5; padding: 5px;" |
* Coronary arteriography
|- style="background: #DCDCDC; padding: 5px;" |


==Classification==
==Classification==
Line 19: Line 383:
{{familytree/end}}
{{familytree/end}}


==Overview UTI==
=='''Code to Fix Refereneces'''==
A urinary tract infection is an infection that involves any part of the [[urinary tract]]. It can result due to the invasion by a bacteria, virus, fungus or any other pathogen. The most common cause of a [[urinary tract infection]] is a bacterial [[infection]]. Various factors are associated with the risk of developing a urinary tract infection. A common cause of the [[urinary tract infection]] in hospital settings is the urinary catheter placement.
<br style="clear:both" />
 
Depending on the site of the infection a [[UTI]] can be classified as either upper or lower [[UTI]]. [[UTI|Lower UTI]] includes [[urethritis]], [[prostatitis]], [[asymptomatic bacteriuria]] and [[cystitis]] (bladder infection) where as [[UTI|Upper UTI]] may include Pyelonephritis (infection of the kidney) and rarely uretritis (infection of the ureters). Each subtype of [[urinary tract infection]] can also be sub classified on the basis of [[duration]], [[etiology]] or therapeutic approach as [[acute]], [[chronic]] or [[recurrent]] and as [[uncomplicated]] or [[complicated]] infections.
 
The urine is normally sterile, a urinary tract infection occurs when the normally sterile [[urinary tract]] is infected by [[bacteria]], which leads to irritation and [[inflammation]]. Females are more prone to the development of [[UTI]]s because of their relatively shorter [[urethra]]. [[Pyelonephritis]] and [[Cystitis]] result mostly from ascending infections from the urethra ([[Urethritis]]) but can also result from descending infections i.e hematogenous spread, or by the [[lymphatic system]]. The condition more often affects women, but can affect either gender and all age groups. Bacteria does not have to travel as far to enter the [[bladder]], which is in part due to the relatively short distance between the opening of the [[urethra]] and the [[anus]]. The pathogenesis of a complicated [[UTI]] may include obstruction and stasis of urine flow.<ref name="pmid10969044">{{cite journal| author=Hooton TM| title=Pathogenesis of urinary tract infections: an update. | journal=J Antimicrob Chemother | year= 2000 | volume= 46 Suppl A | issue=  | pages= 1-7 | pmid=10969044 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10969044  }} </ref> ''[[escherichia coli]] ("E. coli")'', a bacterium found in the lower gastrointestinal tract is one of the most common culprits. [[Diabetes]], [[Crohn's disease]], iatrogenic causes, [[endometriosis]], [[pelvic inflammatory disease]], [[urinary obstruction]], and [[bladder incontinence]] are some other risk factors for acquiring a [[UTI]]. An important aspect in the management of [[UTI]]s is that the individual infection must be differentiated from various causes of [[dysuria]] such as [[cystitis]], [[acute pyelonephritis]], [[urethritis]], [[prostatitis]], [[vulvovaginitis]], [[urethral stricture]]s or diverticula, [[benign prostatic hyperplasia]] and [[neoplasm]]s such as [[renal cell carcinoma]] and cancers of the bladder, prostate, and penis.<ref name="pmid11989635">{{cite journal| author=Bremnor JD, Sadovsky R| title=Evaluation of dysuria in adults. | journal=Am Fam Physician | year= 2002 | volume= 65 | issue= 8 | pages= 1589-96 | pmid=11989635 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11989635  }} </ref><ref name="pmid9606306">{{cite journal| author=Kurowski K| title=The woman with dysuria. | journal=Am Fam Physician | year= 1998 | volume= 57 | issue= 9 | pages= 2155-64, 2169-70 | pmid=9606306 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9606306  }} </ref>
 
A recent challenge in combating [[UTI]]s is the fact that the pathogens are developing resistance to various antibiotics very fast.<ref name="pmid15206056">{{cite journal| author=Hooton TM, Besser R, Foxman B, Fritsche TR, Nicolle LE| title=Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. | journal=Clin Infect Dis | year= 2004 | volume= 39 | issue= 1 | pages= 75-80 | pmid=15206056 | doi=10.1086/422145 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15206056  }} </ref> A large proportion of patients with acute uncomplicated urinary infections will recover without treatment within a few days or weeks. If left untreated, some patients may progress to develop recurrent infection, [[cystitis]], [[pyelonephritis]], [[hematuria]], and rarely [[renal failure]]. [[Prognosis]] is generally good for lower [[UTI]]s. The majority of patients with cystitis do not have recurrence or complications after treatment.<ref name=nid>Urinary Tract Infections in Adults. NIDDK 2016. http://www.niddk.nih.gov/health-information/health-topics/urologic-disease/urinary-tract-infections-in-adults/Pages/facts.aspx. Accessed on February 9, 2016</ref> A detailed and thorough medical history from the patient is necessary. Specific areas of focus when obtaining a history from the patient include use of urinary catheters,  [[pregnancy]], sexual history, [[diabetes]], recent antibiotic use, history of renal disease, [[urinary incontinence]], and [[urinary retention]]. Symptoms of cystitis include abnormal urine color (cloudy), blood in the urine, [[frequent urination]] or [[urgent need to urinate]], painful urination, pressure in the lower pelvis or back, [[flank pain]], [[back pain]], [[nausea]], [[vomiting]], and [[chills]].<ref name=hhh> Cystitis-acute. MedlinePlus.https://www.nlm.nih.gov/medlineplus/ency/article/000526.htm Accessed on February 9, 2016</ref> Patients with an uncomplicated [[UTI]] are usually well-appearing. A thorough physical exam is very helpful in differentiating Upper from Lower [[UTI]]]s and to diagnose exactly within these categories too. Common physical examination findings of cystitis include [[fever]] and suprapubic tenderness where as pyelonephritis also has flank tenderness and chills.<ref name="pmid22010614">{{cite journal| author=Colgan R, Williams M| title=Diagnosis and treatment of acute uncomplicated cystitis. | journal=Am Fam Physician | year= 2011 | volume= 84 | issue= 7 | pages= 771-6 | pmid=22010614 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22010614  }} </ref> Laboratory tests used in the diagnosis of a [[UTI]] include [[urinalysis]] and [[urine culture]]. Laboratory findings consistent with the diagnosis of a [[UTI]] include pyuria and either [[white blood cell]]s (WBCs) or [[red blood cells]] (RBCs) on urinalysis and a positive urine culture. Leukocyte esterase test and nitrite test are very important in this regard. Antimicrobial therapy is indicated in case of a symptomatic [[UTI]].  The treatment of a [[UTI]] depends on the type of the disease, the disease course (acute uncomplicated vs. complicated), history of the individual and the rates of [[Drug resistance|resistance]] in the community. Preventative measures to avoid a [[UTI]] include abstinence from sexual activity, use of barrier contraception during sexual intercourse, urinating after intercourse, increasing fluid intake and frequency of urination, and use of [[estrogen]] (among [[Postmenopausal|post-menopausal]] women). Single-dose [[prophylactic]] antimicrobial therapy prior to sexual intercourse may be administered to patients who have recurrent episodes of cystitis that are associated with sexual activity.
 
==Epidemiology==
*Worldwide, the [[prevalence]] of community associated [[UTI]] is 7000 per 100,000 persons.<ref name="pmid26694621">{{cite journal| author=Tandogdu Z, Wagenlehner FM| title=Global epidemiology of urinary tract infections. | journal=Curr Opin Infect Dis | year= 2016 | volume= 29 | issue= 1 | pages= 73-9 | pmid=26694621 | doi=10.1097/QCO.0000000000000228 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26694621  }} </ref>
*The [[prevalence]] of hospital associated UTI is 129, 196 and 24000 per 100,000 persons in the United States, Europe and developing countries, respectively.<ref name="pmid26694621">{{cite journal| author=Tandogdu Z, Wagenlehner FM| title=Global epidemiology of urinary tract infections. | journal=Curr Opin Infect Dis | year= 2016 | volume= 29 | issue= 1 | pages= 73-9 | pmid=26694621 | doi=10.1097/QCO.0000000000000228 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26694621  }} </ref>
*The annual [[incidence]] of urinary tract infection in women is 1200 per 100,000 persons.
*The incidence of asymptomatic  bacteriuria in pregnant women is 5900 per 100,000 persons.<ref name="pmid2583335">{{cite journal| author=Golan A, Wexler S, Amit A, Gordon D, David MP| title=Asymptomatic bacteriuria in normal and high-risk pregnancy. | journal=Eur J Obstet Gynecol Reprod Biol | year= 1989 | volume= 33 | issue= 2 | pages= 101-8 | pmid=2583335 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2583335  }} </ref><ref name="pmid18826482">{{cite journal| author=Schnarr J, Smaill F| title=Asymptomatic bacteriuria and symptomatic urinary tract infections in pregnancy. | journal=Eur J Clin Invest | year= 2008 | volume= 38 Suppl 2 | issue=  | pages= 50-7 | pmid=18826482 | doi=10.1111/j.1365-2362.2008.02009.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=18826482  }} </ref>
*The incidence of [[cystitis]] and [[pyelonephritis]] in pregnant woman having asymptomatic [[bacteriuria]] is 3300 and 66000 per 100,000 persons.<ref>Czaja, Christopher A., et al. "Population-based epidemiologic analysis of acute pyelonephritis." Clinical Infectious Diseases 45.3 (2007): 273-280.</ref>
*The incidence of recurrence of urinary tract infection in young healthy women is 25000 per 100,000 persons and there is increase in the recurrent rates with every subsequent infection.<ref name="pmid22417256">{{cite journal| author=Hooton TM| title=Clinical practice. Uncomplicated urinary tract infection. | journal=N Engl J Med | year= 2012 | volume= 366 | issue= 11 | pages= 1028-37 | pmid=22417256 | doi=10.1056/NEJMcp1104429 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22417256  }} </ref>
*The incidence of pyelonephritis among healthy women is 120 and 30-40 per 100,000 persons in the outpatient and inpatient setting respectively.<ref>Czaja, Christopher A., et al. "Population-based epidemiologic analysis of acute pyelonephritis." Clinical Infectious Diseases 45.3 (2007): 273-280.</ref>
*The incidence of pyelonephritis in male population is 20 and 10 cases per 100,000 persons in the outpatient and inpatient setting respectively.<ref>Czaja, Christopher A., et al. "Population-based epidemiologic analysis of acute pyelonephritis." Clinical Infectious Diseases 45.3 (2007): 273-280.</ref>
*The incidence of UTI is higher in sexually active women than postmenopausal women.<ref>Jackson, Sara L., et al. "Predictors of urinary tract infection after menopause: a prospective study." The American journal of medicine 117.12 (2004): 903-911.</ref><ref name="pmid22417256">{{cite journal| author=Hooton TM| title=Clinical practice. Uncomplicated urinary tract infection. | journal=N Engl J Med | year= 2012 | volume= 366 | issue= 11 | pages= 1028-37 | pmid=22417256 | doi=10.1056/NEJMcp1104429 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22417256  }} </ref><ref name="pmid8672152">{{cite journal| author=Hooton TM, Scholes D, Hughes JP, Winter C, Roberts PL, Stapleton AE et al.| title=A prospective study of risk factors for symptomatic urinary tract infection in young women. | journal=N Engl J Med | year= 1996 | volume= 335 | issue= 7 | pages= 468-74 | pmid=8672152 | doi=10.1056/NEJM199608153350703 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8672152  }} </ref>
*There is high incidence of urinary tract infection in immunocompromised, elderly, diabetic, and individuals with indwelling catheters.<ref>Nicolle, Lindsay E., et al. "Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults." Clinical Infectious Diseases (2005): 643-654.</ref><ref name="pmid21404794">{{cite journal| author=Woodford HJ, George J| title=Diagnosis and management of urinary infections in older people. | journal=Clin Med (Lond) | year= 2011 | volume= 11 | issue= 1 | pages= 80-3 | pmid=21404794 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21404794  }} </ref>


==Journal Reference==
==Journal Reference==
Line 47: Line 393:


==Pathology image reference/website==
==Pathology image reference/website==
<ref name= "Libre1 Pathology"> Libre Pathology https://librepathology.org/wiki/File:Cystitis_cystica_et_glandularis_-_alt_--_intermed_mag.jpg Accessed on Jan 13, 2017 </ref>
<ref name="Libre1 Pathology">Libre Pathology https://librepathology.org/wiki/File:Cystitis_cystica_et_glandularis_-_alt_--_intermed_mag.jpg Accessed on Jan 13, 2017 </ref>


==Radiopedia Image reference==
==Radiopedia Image reference==


<ref name="https://radiopaedia.org/">Radiopaedia.org. Case courtesy of Dr David Little. From the case <a href="https://radiopaedia.org/cases/39307">rID: 39307</ref>
<ref name="https://radiopaedia.org/">Radiopaedia.org. Case courtesy of Dr David Little. From the case <a href="https://radiopaedia.org/cases/39307">rID: 39307</ref>
 
==Color codes for table==
 
'''BLUE: '''|align="center" style="background:#4479BA; color: #FFFFFF;" |
'''GRAY: '''|style="background: #F5F5F5; padding: 5px text-align:center" | +<br>
'''KHAKI:'''|style="background: #F0E68C; padding: 5px text-align:center" | +<br>
'''PALE TORQOUI...''':|style="background: #AFEEEE; padding: 5px text-align:center" | -<br>
'''Brown:'''|style="background: #A52A2A; padding: 5px text-align:center" | +<br>


==Image copying==
==Image copying==
Line 64: Line 418:


{|
{|
|-style="background: #4479BA; color: #FFFFFF; text-align: center;"
|- style="background: #4479BA; color: #FFFFFF; text-align: center;"
! rowspan="2" |<small>Diseases</small>
! rowspan="2" |<small>Diseases</small>
! colspan="3" |<small>Diagnostic tests</small>
! colspan="3" |<small>Diagnostic tests</small>
Line 86: Line 440:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Cystitis
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Cystitis
|style="background: #F5F5F5; padding: 5px;" |*Nitrite +ve  
| style="background: #F5F5F5; padding: 5px;" |*Nitrite +ve  
<nowiki>*</nowiki>Leukocyte estrase+ve
<nowiki>*</nowiki>Leukocyte estrase+ve


Line 92: Line 446:


<nowiki>*</nowiki>RBCs
<nowiki>*</nowiki>RBCs
|style="background: #F5F5F5; padding: 5px; text-align:center"|>100,000CFU/mL
| style="background: #F5F5F5; padding: 5px; text-align:center" |>100,000CFU/mL
| style="background: #F5F5F5; padding: 5px;" |Urinary culture
| style="background: #F5F5F5; padding: 5px;" |Urinary culture
|style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
|style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px;text-align:center" | -
| style="background: #F5F5F5; padding: 5px;text-align:center" | -
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
|style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
|style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
|style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
|style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
*Recent catheterisation
*Recent catheterisation
*[[Pregnancy]]
*[[Pregnancy]]
Line 111: Line 465:
*Known abnormality of the urinary tract
*Known abnormality of the urinary tract
*[[BPH]] or [[HIV]]
*[[BPH]] or [[HIV]]
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Imaging studies help differentiate the type
* Imaging studies help differentiate the type
* May company back pain, nausea, vomiting and chills
* May company back pain, nausea, vomiting and chills
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Urethritis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Urethritis
|style="background: #F5F5F5; padding: 5px;" |*Positive leukocyte esterase test or >10 WBCs
| style="background: #F5F5F5; padding: 5px;" |*Positive leukocyte esterase test or >10 WBCs
<nowiki>*</nowiki>Mucous threads in the morning urine
<nowiki>*</nowiki>Mucous threads in the morning urine


|style="background: #F5F5F5; padding: 5px; text-align:center" | -
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
| style="background: #F5F5F5; padding: 5px;" |*Gram stain
| style="background: #F5F5F5; padding: 5px;" |*Gram stain


<nowiki>*</nowiki>Mucoid or purulent discharge
<nowiki>*</nowiki>Mucoid or purulent discharge
|style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px;text-align:center" | -
| style="background: #F5F5F5; padding: 5px;text-align:center" | -
| style="background: #F5F5F5; padding: 5px;text-align:center" | Urethral discharge
| style="background: #F5F5F5; padding: 5px;text-align:center" | Urethral discharge
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
|style="background: #F5F5F5; padding: 5px;" | ✔  
| style="background: #F5F5F5; padding: 5px;" | ✔  
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
|style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
:* Prior [[STD]]s
:* Prior [[STD]]s
:* [[Urinary tract infection|Urinary tract infections]]
:* [[Urinary tract infection|Urinary tract infections]]
Line 138: Line 492:
:* Recent intercourse
:* Recent intercourse
:* Recent catheterisation
:* Recent catheterisation
|style="background: #F5F5F5; padding: 5px;" |Tachycardia, diaphoresis, hypertension, tremors, mydriasis, positional nystagmus, tachypnea
| style="background: #F5F5F5; padding: 5px;" |Tachycardia, diaphoresis, hypertension, tremors, mydriasis, positional nystagmus, tachypnea
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Bacterial Vulvovagintis
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Bacterial Vulvovagintis


|style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px; text-align:center" | -
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
| style="background: #F5F5F5; padding: 5px;" |Gram Stain
| style="background: #F5F5F5; padding: 5px;" |Gram Stain
|style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px;text-align:center" |-
| style="background: #F5F5F5; padding: 5px;text-align:center" | -
|style="background: #F5F5F5; padding: 5px;text-align:center" | Vaginal discharge 
| style="background: #F5F5F5; padding: 5px;text-align:center" | Vaginal discharge 
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |
Line 165: Line 519:


|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" | Cervicitis
| style="background: #DCDCDC; padding: 5px; text-align: center;" | Cervicitis
|style="background: #F5F5F5; padding: 5px; text-align:center"| -
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
|style="background: #F5F5F5; padding: 5px; text-align:center"| -
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
|style="background: #F5F5F5; padding: 5px; text-align:center" | culture for [[gonococcal]] cervicitis
| style="background: #F5F5F5; padding: 5px; text-align:center" | culture for [[gonococcal]] cervicitis
|style="background: #F5F5F5; padding: 5px; text-align:center"| ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |-
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
|style="background: #F5F5F5; padding: 5px; text-align:center"|
| style="background: #F5F5F5; padding: 5px; text-align:center" |
 
endocervical exudate
endocervical exudate
| style="background: #F5F5F5; padding: 5px; text-align:center" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |
|style="background: #F5F5F5; padding: 5px; text-align:center" |-
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
|style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
|style="background: #F5F5F5; padding: 5px; text-align:center"|-
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
| style="background: #F5F5F5; padding: 5px; text-align:center" |-
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
|style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |
* Abnormal vaginal bleeding after intercourse or after [[menopause]]
* Abnormal vaginal bleeding after intercourse or after [[menopause]]
Line 191: Line 544:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Prostatitis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Prostatitis
|style="background: #F5F5F5; padding: 5px;" | 10-20 leukocytes for acute and chronic bacterial subtypes
| style="background: #F5F5F5; padding: 5px;" | 10-20 leukocytes for acute and chronic bacterial subtypes
|style="background: #F5F5F5; padding: 5px; text-align:center" | Identifies causative bacteria (in bacterial subtypes)
| style="background: #F5F5F5; padding: 5px; text-align:center" | Identifies causative bacteria (in bacterial subtypes)
| style="background: #F5F5F5; padding: 5px;" |  
| style="background: #F5F5F5; padding: 5px;" |  
*Urine Culture  
*Urine Culture  
|style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px;text-align:center" |-
| style="background: #F5F5F5; padding: 5px;text-align:center" | -
| style="background: #F5F5F5; padding: 5px;text-align:center" |-
| style="background: #F5F5F5; padding: 5px;text-align:center" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px; text-align:center" |-
| style="background: #F5F5F5; padding: 5px; text-align:center" | -
|style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
|style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
|style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Urogenital disorders
* Urogenital disorders
* Recent [[catheterization]] or other genitourinary instrumentation
* Recent [[catheterization]] or other genitourinary instrumentation
* History of [[UTI|UTIs]]
* History of [[UTI|UTIs]]
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* In acute prostatitis, palpation reveals a tender and enlarged prostate<sup>[[Prostatitis physical examination|[1][3]]]</sup>
* In acute prostatitis, palpation reveals a tender and enlarged prostate<sup>[[Prostatitis physical examination|[1][3]]]</sup>
* In chronic prostatitis, palpation reveals a tender and soft (boggy) prostate<sup>[[Prostatitis physical examination|[1]]]</sup>
* In chronic prostatitis, palpation reveals a tender and soft (boggy) prostate<sup>[[Prostatitis physical examination|[1]]]</sup>
* A prostate massage should never be done in a patient with suspected acute prostatitis, since it may induce [[sepsis]]
* A prostate massage should never be done in a patient with suspected acute prostatitis, since it may induce [[sepsis]]
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Epididymitis
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epididymitis
|style="background: #F5F5F5; padding: 5px;" | Hematuria may be seen
| style="background: #F5F5F5; padding: 5px;" | Hematuria may be seen
|style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | Culture
| style="background: #F5F5F5; padding: 5px;" | Culture
|style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;text-align:center" |✔
| style="background: #F5F5F5; padding: 5px;text-align:center" |✔
|style="background: #F5F5F5; padding: 5px;" | +/- urethral discharge
| style="background: #F5F5F5; padding: 5px;" | +/- urethral discharge
| style="background: #F5F5F5; padding: 5px;" |  ✔   
| style="background: #F5F5F5; padding: 5px;" |  ✔   
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
Line 235: Line 588:
*If equivocal do surgical exploration
*If equivocal do surgical exploration
|-
|-
|style="background: #DCDCDC; padding: 5px; text-align: center;" |Syphilis (STD)
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Syphilis (STD)
|style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |Darkfield Microscopy
| style="background: #F5F5F5; padding: 5px;" |Darkfield Microscopy
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" | +/-
| style="background: #F5F5F5; padding: 5px;" |-
|style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" | ✔
|style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
|style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
* History of STD
* History of STD
* HIV
* HIV
Line 263: Line 616:
| style="background: #F5F5F5; padding: 5px;" | Recommended
| style="background: #F5F5F5; padding: 5px;" | Recommended
Hematuria may be seen
Hematuria may be seen
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |DRE + Serum PSA
| style="background: #F5F5F5; padding: 5px;" |DRE + Serum PSA
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
Line 289: Line 642:
| style="background: #F5F5F5; padding: 5px;" | Recomended
| style="background: #F5F5F5; padding: 5px;" | Recomended
Hematuria may be seen
Hematuria may be seen
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |Imaging and biopsy
| style="background: #F5F5F5; padding: 5px;" |Imaging and biopsy
| style="background: #F5F5F5; padding: 5px; text-align:center" | +-
| style="background: #F5F5F5; padding: 5px; text-align:center" | +-
| style="background: #F5F5F5; padding: 5px;text-align:center" |-
| style="background: #F5F5F5; padding: 5px;text-align:center" | -
| style="background: #F5F5F5; padding: 5px;text-align:center" |
| style="background: #F5F5F5; padding: 5px;text-align:center" |
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px;" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px; text-align:center" | ✔
| style="background: #F5F5F5; padding: 5px;" |-
| style="background: #F5F5F5; padding: 5px;" | -
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Sudden inability to [[urinate]]
* Sudden inability to [[urinate]]

Latest revision as of 15:49, 7 March 2018


Wikidoc Internal Medicine Texbook
Subject Endocrinology Gastroenterology Rheumatology Pulmonology Nephrology Hematology Total
Number of Microchapters Total Left Total Left Total Left Total Left Total Left Total Left
71 39 96 89 54 47 58 46 59 64 51 47 332
Projected Microchapters 50 111 59 59 80 59 418
Days Projected
  • If one chapter takes 10 days/fellow
  • Number of fellows = 15
  • 15 chapters are completed in 10 days
35 days 75 days 40 days 40 days 55 days 40 days 280 days
Review Processing Time (days) 14 14 14 14 14 14 84 days
Expected Time for each Chapter (days) 49 89 54 54 69 54 364 days
Expected Time line October 2017, 1st week January 2018,1st week February 2018, 4th week April 2018, 3rd week July 2018, 1st week August 2018, 4th week
Wikidoc Other Textbooks
Subject Psychiatry Neurology Peds/Developmental Dermatology ObGyn Ophthalmology Nutrition Total
Number of Microchapters Total Left Total Left Total Left Total Left Total Left Total Left Total Left
36 36 77 71 49 49 18 14 33 27 18 17 17 15 229
Projected Microchapters 45 89 60 17 35 21 19 286
Days projected
  • If one chapter takes 10 days/fellow
  • Number of fellows = 15
  • 15 chapters are completed in 10 days
30 days 60 days 40 days 14 days 21 days 16 days 15 days 196 days
Review Processing Time (days) 14 14 14 14 14 14 14 98 days
Expected Time for each Chapter (days) 44 74 54 28 35 30 29 294 days
Expected Time Line October 2018, 3rd week January 2019, 1st week March 2019, 1st week April 2019, 1st week May 2019, 2nd week June 2019, 2nd week July 2019, 2nd week
 
 
 
 
 
 
 
 
 
 
 
 
Viral Hepatitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hepatitis A
 
Hepatitis B
 
Hepatitis C
 
Hepatitis D
 
Hepatitis E
 
Hepatitis F
 
Hepatitis G
 
Other
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EBV hepatitis
CMV hepatitis
HSV hepatitis
Coxsackie B virus hepatitis



 
 
 
 
 
 
 
 
 
 
 
 
Non-infectious Hepatitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alcoholic hepatitis
 
 
 
 
a-1 antitrypsin defieciency
 
Autoimmune hepatitis
 
Obstructive hepatitis
 
Drug related hepatitis
 
Toxin related hepatitis
 
Ischemic hepatitis
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gall stone
•Tumor
 
Isoniazid
NSAIDs
•Beta-lactam antibiotics
•Sulfa-containing drugs
HAART
 
Chemicals
 
 
 
 
 

Chest Pain

Classification

Differentials on the basis of Etiology Disease Clinical manifestations Diagnosis
Symptoms Risk factors Physical exam Lab Findings EKG Imaging Gold standard
Onset Duration Quality of Pain Cough Fever Dyspnea Weight loss Associated Features
Stable Angina[1] Sudden (acute) 2-10 minutes
  • Heaviness/pressure/ tightness/squeezing/ burning (Levine's sign)
  • Retrosternal or left sided chest pain
- - +/- - Dyslipidemia, hypertension, smoking, family history of premature disease, and diabetes
  • Cardiac enzymes normal
  • Exercise EKG: ST-segment depression
  • Exercise Stress Testing: Decreased myocardial perfusion
  • Transthoracic echocardiography: Ejection fraction <50 percent
  • Coronary angiography
Unstable Angina[2][3][4] Acute 10-20 minutes
  • Same as stable angina but often more severe
- - + - Dyslipidemia, hypertension, smoking, family history of premature disease, and diabetes
  • ST-depression
  • New T wave inversions
  • Transient ST-elevation
  • Echocardiography: Ejection fraction <50 percent
  • Exercise Stress Testing: Decreased myocardial perfusion
  • Invasive coronary angiography
Myocardial Infarction[5][6][7][8] Acute Commonly > 20 minutes
  • Same as stable angina but often more severe
- - + - Dyslipidemia, hypertension, smoking, family history of premature disease, and diabetes
  • Hypotension
  • Tachycardia
  • ST elevation MI (STEMI)
  • Non-ST elevation MI (NSTEMI) or Non Q wave
  • Echocardiography: ↓ EF
  • CCTA: Coronory artery stenosis
  • CMRI: Coronory vessels stenosis
  • MPI on SPECT or PET scanning: Decreased myocardial perfusion.
  • CCTA combined with MPI
Cardiac Vasospastic/ Prinzmetal/ Variant Angina[9][10] Gradual in onset and offset Episodic, gradual in onset and offset. Chest discomfort described as squeezing, tightness, pressure, constriction, strangling, burning, heart burn, fullness in the chest, a band-like sensation, knot in the center of the chest, lump in the throat, ache, and heavy weight on chest - - + -
  • Nausea, sweating, dizziness, dyspnea, and palpitations
  • Associated with other vasospastic disorders, such as Raynaud's phenomenon and migraine headache
  • Multiple drugs (ephedrine-based products, cocaine, marijuana, alcohol, butane, sumatriptan, and amphetamines)
  • Food-born botulism
  • Guide wire or balloon dilatation while doing PCI
  • Magnesium deficiency
Tachycardia, hypertension, diaphoresis, and a gallop rhythm 
  • Urine drug screen may be positive for cocaine or other drugs
  • Transient (less than 15 minutes) ischemic ST changes in multiple leads
  • A tall and broad R wave,
  • Disappearance of the S wave
  • A taller T wave
  • Negative U waves
  • Stress testing: normal noninvasive stress test, exercise-induced spasm with ST-segment elevation,
  • Stress echocardiography with ergonovine provocation: Vasospasm of coronory vessels
  • Coronary arteriography: Epicardial spasm
  • Coronary arteriography
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UTI
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Uppper
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Lower
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pyelonephritis
 
 
 
Cystitis
 
 
 
 
 
 
 
 
 
Prostatitis
 
 
 
 
 
 
 
 
Uretheritis
 
 
 
 
 
 
 
 
Asymptomatic Bacteriuria
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pyelonephritis
 
Etiology
 
Pathogen
 
Duration and Treatment
 
 
 
Acute Bacterial*Chronic bacterial*Inflammatory chronic*Non-inflammatory chronic*Asymptomatic
 
 
 
 
 
 
Non-infectious
 
Infectious
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Traumatic cystitis*Interstitial Cystitis*Eosinophilic cystitis*Hemorrhagic cystitis*Foreign body cystitis*Cystitis cystica*Emphysematous cystitis*Cystitis glandularis
 
*Bacteria*Fungi*Viruses*Parasites
 
*Acute uncomplicated cystitis*Complicated cystitis*Recurrent/Chronic Cystitis
 
 
 
 
 
 
 
 
 
 
 
 
*urinary crystals*Chemicals*Stevens-Johnson syndrome*Spermicides
 

Code to Fix Refereneces


Journal Reference

Raas-Rothschild A, Spiegel R (2010 Jan 28). "Mucolipidosis III Gamma". GeneReviews®. PMID 20301784. Check date values in: |access-date=, |date= (help); |access-date= requires |url= (help)

Book Reference

[11]

Pathology image reference/website

[12]

Radiopedia Image reference

[13]

Color codes for table

BLUE: |align="center" style="background:#4479BA; color: #FFFFFF;" | GRAY: |style="background: #F5F5F5; padding: 5px text-align:center" | +
KHAKI:|style="background: #F0E68C; padding: 5px text-align:center" | +
PALE TORQOUI...:|style="background: #AFEEEE; padding: 5px text-align:center" | -
Brown:|style="background: #A52A2A; padding: 5px text-align:center" | +

Image copying

Xanthogranulomatous Pyelonephritis

Image copying with text

CT Scan Emphysematous Cystitis


Table for D/D of cystitis

Diseases Diagnostic tests Physical Examination Symptoms Past medical history Other Findings
Urinalysis Urine Culture Gold Standard Fever Suprapubic Tenderness Discharge Inguinal Lymphadenopathy Hematuria Pyuria Frequency Urgency Dysuria
Cystitis *Nitrite +ve

*Leukocyte estrase+ve

*WBCs

*RBCs

>100,000CFU/mL Urinary culture -
  • Recent catheterisation
  • Pregnancy
  • recent intercourse
  • Diabetes
  • Personal or Family History of UTI
  • Known abnormality of the urinary tract
  • BPH or HIV
  • Imaging studies help differentiate the type
  • May company back pain, nausea, vomiting and chills
Urethritis *Positive leukocyte esterase test or >10 WBCs

*Mucous threads in the morning urine

- *Gram stain

*Mucoid or purulent discharge

- Urethral discharge - - -
Tachycardia, diaphoresis, hypertension, tremors, mydriasis, positional nystagmus, tachypnea
Bacterial Vulvovagintis - - Gram Stain - Vaginal discharge 
  • Number and type of sexual partners (new, casual, or regular)
  • Prior STDs
  • Previous history of symptomatic BV in female partner (in homosexual women)
  • Fishy odor from the vagina (Whiff test)
  • Thin, white/gray homogeneous vaginal discharge
  • Microscopy (wet prep) and vaginal pH 
  • Clue cells
Cervicitis - - culture for gonococcal cervicitis -

endocervical exudate

- - -
  • Abnormal vaginal bleeding after intercourse or after menopause
  • Abnormal vaginal discharge
  • Painful sexual intercourse
  • Pressure or heaviness in the pelvis
1-a purulent or mucopurulent endocervical exudate

2-Sustained endocervical bleeding easily induced by a cotton swab

3->10 WBC in vaginal fluid, in the absence of trichomoniasis, may indicate endocervical inflammation caused specifically by C. trachomatis or N. gonorrhea

Prostatitis 10-20 leukocytes for acute and chronic bacterial subtypes Identifies causative bacteria (in bacterial subtypes)
  • Urine Culture
- - -
  • Urogenital disorders
  • Recent catheterization or other genitourinary instrumentation
  • History of UTIs
  • In acute prostatitis, palpation reveals a tender and enlarged prostate[1][3]
  • In chronic prostatitis, palpation reveals a tender and soft (boggy) prostate[1]
  • A prostate massage should never be done in a patient with suspected acute prostatitis, since it may induce sepsis
Epididymitis Hematuria may be seen Culture +/- urethral discharge -
  • Scrotal pain: starts gradually, is usually unilateral and localized posterior to the testis
  • Scrotal swelling
  • Scrotal wall erythema
  • Constitutional symptoms: feeling of hotness, chills, nausea and vomiting
*Ultrasound in patients with acute testicular pain to assess for testicular torsion
  • If equivocal do surgical exploration
Syphilis (STD) - - Darkfield Microscopy +/- - - - - - - -
  • History of STD
  • HIV
  • Immunosupression
  • Previous history of chancre
  • May be asymptomatic
  • Painless chancre in primary syphilis
  • Secondary syphilis may have generalised features and condylomata late
  • Tertiary syphilis can have neurosyphilis, cardiovascular syphilis and gummas
BPH Recommended

Hematuria may be seen

- DRE + Serum PSA - - - -
Neoplasms Recomended

Hematuria may be seen

- Imaging and biopsy +- - - -
Pyelonephritis
  • Leukocytes
  • Nitrite +ve
Identifies causative bacteria Imaging and culture ✔ + Flank Pain
  • History of Pyelonephritis
  • Recent history of Hospitalisation
  • Nephrolithiasis
  • Immunosupression
  • Costovertebral angle tenderness
  • Patient is in acute distress
  • Look for obstructive causes

References

  1. Fihn SD, Gardin JM, Abrams J, Berra K, Blankenship JC, Dallas AP, Douglas PS, Foody JM, Gerber TC, Hinderliter AL, King SB, Kligfield PD, Krumholz HM, Kwong RY, Lim MJ, Linderbaum JA, Mack MJ, Munger MA, Prager RL, Sabik JF, Shaw LJ, Sikkema JD, Smith CR, Smith SC, Spertus JA, Williams SV, Anderson JL (December 2012). "2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Circulation. 126 (25): e354–471. doi:10.1161/CIR.0b013e318277d6a0. PMID 23166211.
  2. Tatum JL, Jesse RL, Kontos MC, Nicholson CS, Schmidt KL, Roberts CS, Ornato JP (January 1997). "Comprehensive strategy for the evaluation and triage of the chest pain patient". Ann Emerg Med. 29 (1): 116–25. PMID 8998090.
  3. Ornato JP (August 1999). "Chest pain emergency centers: improving acute myocardial infarction care". Clin Cardiol. 22 (8 Suppl): IV3–9. PMID 10492848.
  4. Gibler WB (August 1995). "Evaluation of chest pain in the emergency department". Ann. Intern. Med. 123 (4): 315, author reply 317–8. PMID 7611601.
  5. Svavarsdóttir AE, Jónasson MR, Gudmundsson GH, Fjeldsted K (June 1996). "Chest pain in family practice. Diagnosis and long-term outcome in a community setting". Can Fam Physician. 42: 1122–8. PMC 2146490. PMID 8704488.
  6. Klinkman MS, Stevens D, Gorenflo DW (April 1994). "Episodes of care for chest pain: a preliminary report from MIRNET. Michigan Research Network". J Fam Pract. 38 (4): 345–52. PMID 8163958.
  7. Bösner S, Becker A, Haasenritter J, Abu Hani M, Keller H, Sönnichsen AC, Karatolios K, Schaefer JR, Seitz G, Baum E, Donner-Banzhoff N (2009). "Chest pain in primary care: epidemiology and pre-work-up probabilities". Eur J Gen Pract. 15 (3): 141–6. doi:10.3109/13814780903329528. PMID 19883149.
  8. Ebell MH (March 2011). "Evaluation of chest pain in primary care patients". Am Fam Physician. 83 (5): 603–5. PMID 21391528.
  9. PRINZMETAL M, KENNAMER R, MERLISS R, WADA T, BOR N (September 1959). "Angina pectoris. I. A variant form of angina pectoris; preliminary report". Am. J. Med. 27: 375–88. PMID 14434946.
  10. Kaski JC, Crea F, Meran D, Rodriguez L, Araujo L, Chierchia S, Davies G, Maseri A (December 1986). "Local coronary supersensitivity to diverse vasoconstrictive stimuli in patients with variant angina". Circulation. 74 (6): 1255–65. PMID 3779913.
  11. Braunwald, Eugene. Heart Disease- Fourth Edition. Harvard Medical School: W. B. SAUNDERS COMPANY. p. 1137. ISBN 0-7216-3097-9.
  12. Libre Pathology https://librepathology.org/wiki/File:Cystitis_cystica_et_glandularis_-_alt_--_intermed_mag.jpg Accessed on Jan 13, 2017
  13. Radiopaedia.org. Case courtesy of Dr David Little. From the case <a href="https://radiopaedia.org/cases/39307">rID: 39307